Hemin rescues adrenodoxin, heme a and cytochrome oxidase activity in frataxin-deficient oligodendroglioma cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 7, 2007, Pages 773-780

  Napoli, Eleonora ^a   Morin, Dexter ^a   Bernhardt, Rita ^b   Buckpitt, Alan ^a   Cortopassi, Gino ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Adrenodoxin; Frataxin; Heme; Hemin; Iron sulfur cluster; RNAi; Theraphy

Indexed keywords

ACONITATE HYDRATASE; ADRENODOXIN; CYTOCHROME C OXIDASE; FERROCHELATASE; FRATAXIN; HEME; HEME A; HEMIN; HEMOPROTEIN; IRON SULFUR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FRIEDREICH ATAXIA; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; LYMPHOBLAST; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN CONTENT;

ADRENODOXIN; BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; ELECTRON TRANSPORT COMPLEX IV; HELA CELLS; HEME; HEMIN; HUMANS; IRON-BINDING PROTEINS; IRON-SULFUR PROTEINS; OLIGODENDROGLIOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELLS, CULTURED;

EID: 34250223092     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.04.001     Document Type: Article

References (40)

1. Muhlenhoff U., Richhardt N., Ristow M., Kispal G., and Lill R. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum. Mol. Genet. 11 (2002) 2025-2036
2. Yoon T., and Cowan J.A. Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J. Am. Chem. Soc. 125 (2003) 6078-6084
3. Tan G., Napoli E., Taroni F., and Cortopassi G.A. Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum. Mol. Genet. 12 (2003) 1699-1711
4. Schoenfeld R.A., Napoli E., Wong A., Zhan S., Reutenauer L., Morin D., Buckpitt R., Taroni F., Lonnerdal B., Ristow M., Puccio H., and Cortopassi G.A. Frataxin deficiency alters heme pathway transcripts and decreases mitochondrial heme metabolites in mammalian cells. Hum. Mol. Genet. 14 (2005) 3787-3799
5. Napoli E., Taroni F., and Cortopassi G.A. Frataxin, iron-sulfur clusters, heme, ROS, and aging. Antioxid. Redox Signal. 8 (2006) 506-516
6. Lu C., and Cortopassi G.A. Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch. Biochem. Biophys. 457 (2007) 111-122
7. Lange H., Muhlenhoff U., Denzel M., Kispal G., and Lill R. The heme synthesis defect of mutants impaired in mitochondrial iron-sulfur protein biogenesis is caused by reversible inhibition of ferrochelatase. J. Biol. Chem. 279 (2004) 29101-29108
8. Mansy S.S., and Cowan J.A. Iron-sulfur cluster biosynthesis: toward an understanding of cellular machinery and molecular mechanism. Acc. Chem. Res. 37 (2004) 719-725
9. Tong H., and Rouault T.A. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 3 (2006) 199-210
10. Barros M.H., Nobrega F.G., and Tzagoloff A. Mitochondrial ferredoxin is required for heme A synthesis in Saccharomyces cerevisiae. J. Biol. Chem. 277 (2002) 9997-10002
11. Anderson K.E., Bloomer J.R., Bonkovsky H.L., Kushner J.P., Pierach C.A., Pimstone N.R., and Desnick R.J. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Intern. Med. 142 (2005) 439-450
12. Sarsero J.P., Li L., Wardan H., Sitte K., Williamson R., and Ioannou P.A. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia. J. Gene Med. 5 (2003) 72-81
13. Duby G., Foury F., Ramazzotti A., Herrmann J., and Lutz T. Non-essential function for yeast frataxin in iron-sulfur cluster assembly. Hum. Mol. Genet. 11 (2002) 2635-2643
14. Lesuisse E., Santos R., Matzanke B.F., Knight S.A., Camadro J.M., and Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). Hum. Mol. Genet. 12 (2003) 879-889
15. Park S., Gakh O., O'Neill H.A., Mangravita A., Nichol H., Ferreira G.C., and Isaya G. Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J. Biol. Chem. 278 (2003) 31340-31351
16. Yoon T., and Cowan J.A. Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J. Biol. Chem. 279 (2004) 25943-25946
17. Cortopassi G.A., Danielson S., Alemi M., Zhan S.S., Tong W., Carelli V., Martinuzzi A., Marzuky S., Majamaa K., and Wong A. Mitochondrial disease activates transcripts of the unfolded protein response and cell cycle and inhibits vesicular secretion and oligodendrocyte-specific transcripts. Mitochondrion 6 (2006) 161-175
18. Barros M.H., and Tzagoloff A. Regulation of the heme A biosynthetic pathway in Saccharomyces cerevisiae. FEBS Lett. 516 (2002) 119-123
19. Barros M.H., Nobrega F.G., and Tzagoloff A. Mitochondrial ferredoxin is required for heme A synthesis in Saccharomyces cerevisiae. J. Biol. Chem. 277 (2002) 9997-10002
20. Agar J.N., Krebs C., Frazzon J., Huynh B.H., Dean D.R., and Johnson M.K. IscU as a scaffold for iron-sulfur cluster biosynthesis: sequential assembly of [2Fe-2S] and [4Fe-4S] clusters in IscU. Biochemistry 39 (2000) 7856-7862
21. Atamna H. Heme, iron and the mitochondrial decay of ageing. Ageing Res. Rev. 3 (2004) 303-318
22. Whetsell W.O., Sassa S., and Kappas A. Porphyrin-heme biosynthesis in organotypic cultures of mouse dorsal root ganglia. Effects of heme and lead on porphyrin synthesis and peripheral myelin. J. Clin. Invest. 74 (1984) 600-607
23. Courville C.B. The process of demyelination in the central nervous system: IV. Demyelination as a delayed residual of carbon monoxide asphyxia. J. Nerv. Ment. Dis. 125 (1957) 534-546
24. Wilson J. Cyanide in human disease: a review of clinical and laboratory evidence. Fundam. Appl. Toxicol. 3 (1983) 397-399
25. Matsushima G.K., and Morell P. The neurotoxicant, Cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11 (2001) 107
26. Barreira A.A., Marques W., Sweeney M.G., Davis M.B., Chimelli L., Paçó-Larson M.L., and Wood N.W. A family with Friedreich's ataxia and onion-bulb formations at sural nerve biopsy. Ann. N.Y. Acad. Sci. 883 (1999) 466
27. Al-Mahdawi S., Mouro Pinto R., Varshney D., Lawrence L., Lowrie M.B., Hughes S., Webster Z., Blake J., Cooper J.M., King R., and Pook M.A. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics 88 (2006) 580-590
28. Schalinske K.L., Chen O.S., and Eisenstein R.S. Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. J. Biol. Chem. 273 (1998) 3740-3746
29. Sturm B., Stupphann D., Kaun C., Boesch S., Schranzhofer M., Wojta J., Goldenberg H., and Scheiber-Mojdehkar B. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur. J. Clin. Invest. 35 (2005) 711-717
30. Rustin P., von Kleist-Retzow J.C., Chantrel-Groussard K., Sidi D., Munnich A., and Rotig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354 (1999) 477-479
31. Hausse A.O., Aggoun Y., Bonnet D., Sidi D., Munnich A., Rotig A., and Rustin P. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart 87 (2002) 346-349
32. Rustin P., Rotig A., Munnich A., and Sidi D. Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia. Free Radical Res. 36 (2002) 467-469
33. Moosmann B., and Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Investig. Drugs 11 (2002) 1407-1435
34. Jauslin M.L., Meier T., Smith R.A., and Murphy M.P. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J. 17 (2003) 1972-1974
35. Lenaz G., Bovina C., D'Aurelio M., Fato R., Formiggini G., Genova M.L., Giuliano G., Merlo Pich M., Paolucci U., Parenti Castelli G., and Ventura B. Role of mitochondria in oxidative stress and aging. Ann. N.Y. Acad. Sci. 959 (2002) 199-213
36. Bonkovsky H.L., Healey J.F., Lourie A.N., and Gerron G.G. Intravenous hemealbumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools. Am. J. Gastroenterol. 86 (1991) 1050-1056
37. Schulz H., Pellicioli E.C., and Thony-Meyer L. New insights into the role of CcmC, CcmD and CcmE in the haem delivery pathway during cytochrome c maturation by a complete mutational analysis of the conserved tryptophan-rich motif of CcmC. Mol. Microbiol. 37 (2000) 1379-1388
38. Tan G., Chen L.S., Lonnerdal B., Gellera C., Taroni F.A., and Cortopassi G.A. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells. Hum. Mol. Genet. 10 (2001) 2099-2107
39. Miró O., Cardellach F., Barrientos A., Casademont J., Rötig A., and Rustin P. Cytochrome oxidase assay in minute amounts of skeletal muscle using single wavelength spectrophotometers. J. Neurosci. Methods 80 (1998) 107-111
40. Uhlmann H., Kraft R., and Bernhardt R. C-terminal region of Adrenodoxin affects its structural integrity and determines differences in its electron transfer function to cytochrome P-450. J. Biol. Chem. 269 (1994) 22557-22564